SCHEMBL7716660

SCHEMBL7716660

CCOc1cc(CC(C)(C)C)ccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
TSHR P16473 3/20 0.51
KDM4E B2RXH2 2/20 0.51
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
GAA P10253 2/20 0.48
MAPT P10636 2/20 0.48
ALOX15 P16050 2/20 0.48
HSD17B10 Q99714 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
ESR1 P03372 2/20 0.46
TOP2A P11388 1/20 0.44
ABL1 P00519 1/20 0.43
ABCB1 P08183 1/20 0.43
BCR P11274 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
PIM1 P11309 1/20 0.42
PIM3 Q86V86 1/20 0.42
PIM2 Q9P1W9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10801045 0.88 ALDH1A1 (0.50) ALDH1A1TSHRKDM4EKMT2AMEN1
SCHEMBL10757302 0.87 ALDH1A1 (0.49) ALDH1A1TSHRKDM4EKMT2AMEN1
SCHEMBL12775614 0.84 CALM1 (0.46) ALDH1A1TSHRKDM4EKMT2AMEN1
SCHEMBL426433 0.82 CNR1 (0.58) ALDH1A1TSHRKDM4EKMT2AMEN1
SCHEMBL8342475 0.82 TAAR1 (0.61) ALDH1A1TSHRGAAALOX15TDP1
SCHEMBL10762625 0.82 TRPA1 (0.57) ALDH1A1TSHRKDM4EKMT2AMEN1
SCHEMBL13053303 0.81 KCNH2 (0.48) ALDH1A1TSHRGAATDP1ESR1
SCHEMBL31412813 0.80 ALDH1A1 (0.55) ALDH1A1TSHRKDM4EKMT2AMEN1
SCHEMBL586875 0.80 ALDH1A1 (0.55) ALDH1A1TSHRKDM4EKMT2AMEN1
SCHEMBL20399514 0.79 ALDH1A1 (0.51) ALDH1A1TSHRKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130150376-A1 Novel Sultam Compounds PFIZER INC. (US) 2013-06-13 US disclosed
WO-2011125006-A2 NOVEL SULTAM COMPOUNDS PFIZER INC. (US) 2011-10-13 WO disclosed
US-20110046160-A1 Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases PFIZER, INC. 2011-02-24 US disclosed
US-20110046160-A1 Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases PFIZER, INC. 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150376-A1 Novel Sultam Compounds SULT2A1, SULT1A1, SULT1E1 ALDH1A1 75/4885TSHR 1799/4885KDM4E 3456/4885
US-20110046160-A1 Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases SNCA, PARK7, HTT ALDH1A1 83/4885TSHR 2618/4885KDM4E 3440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.